These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 22612063)

  • 1. The use of 'real-time' complement analysis to differentiate atypical haemolytic uraemic syndrome from other forms of thrombotic microangiopathies.
    Prohászka Z; Varga L; Füst G
    Br J Haematol; 2012 Aug; 158(3):424-5. PubMed ID: 22612063
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of ADAMTS13 activity, platelet count, and serum creatinine to differentiate acquired thrombotic thrombocytopenic purpura from other thrombotic microangiopathies.
    Cataland SR; Yang S; Wu HM
    Br J Haematol; 2012 May; 157(4):501-3. PubMed ID: 22296585
    [No Abstract]   [Full Text] [Related]  

  • 3. Diagnosis and management of complement mediated thrombotic microangiopathies.
    Cataland SR; Wu HM
    Blood Rev; 2014 Mar; 28(2):67-74. PubMed ID: 24534133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of ADAMTS13 in the management of thrombotic microangiopathies including thrombotic thrombocytopenic purpura (TTP).
    Shah N; Rutherford C; Matevosyan K; Shen YM; Sarode R
    Br J Haematol; 2013 Nov; 163(4):514-9. PubMed ID: 24111495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methodologies and clinical utility of ADAMTS-13 activity testing.
    Just S
    Semin Thromb Hemost; 2010 Feb; 36(1):82-90. PubMed ID: 20391299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lupus nephritis combined with renal injury due to thrombotic thrombocytopaenic purpura-haemolytic uraemic syndrome.
    Yu F; Tan Y; Zhao MH
    Nephrol Dial Transplant; 2010 Jan; 25(1):145-52. PubMed ID: 19703836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADAMTS13 deficiency in severe postpartum HELLP syndrome.
    Pourrat O; Coudroy R; Pierre F
    Br J Haematol; 2013 Nov; 163(3):409-10. PubMed ID: 23889130
    [No Abstract]   [Full Text] [Related]  

  • 8. Thrombotic microangiopathies: from empiricism to targeted therapies.
    Coppo P
    Presse Med; 2012 Mar; 41(3 Pt 2):e101-4. PubMed ID: 22317842
    [No Abstract]   [Full Text] [Related]  

  • 9. Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies.
    Scully M; Hunt BJ; Benjamin S; Liesner R; Rose P; Peyvandi F; Cheung B; Machin SJ;
    Br J Haematol; 2012 Aug; 158(3):323-35. PubMed ID: 22624596
    [No Abstract]   [Full Text] [Related]  

  • 10. Consensus opinion on diagnosis and management of thrombotic microangiopathy in Australia and New Zealand.
    Fox LC; Cohney SJ; Kausman JY; Shortt J; Hughes PD; Wood EM; Isbel NM; de Malmanche T; Durkan A; Hissaria P; Blombery P; Barbour TD
    Nephrology (Carlton); 2018 Jun; 23(6):507-517. PubMed ID: 29419916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microangiopathic haemolytic anaemia resembling thrombotic thrombocytopenic purpura in systemic lupus erythematosus: the role of ADAMTS13.
    Lansigan F; Isufi I; Tagoe CE
    Rheumatology (Oxford); 2011 May; 50(5):824-9. PubMed ID: 21149242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombotic microangiopathies: the past as prologue.
    Mannucci PM
    Eur J Intern Med; 2013 Sep; 24(6):484-5. PubMed ID: 23684592
    [No Abstract]   [Full Text] [Related]  

  • 13. Thrombotic Microangiopathy: a Challenging Diagnosis Always.
    Marco-Hernández J; Prieto-González S; Blasco M; Castro P; Cid J; Espinosa G
    Isr Med Assoc J; 2016 Jul; 18(7):437-438. PubMed ID: 28471571
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical utility of ADAMTS-13 testing in suspected thrombotic microangiopathy: an audit of ADAMTS-13 activity assay requests in routine practice from a tertiary hospital.
    Garizio DG; Wilgen U; Williams BA; Kennedy GA
    Pathology; 2012 Dec; 44(7):638-41. PubMed ID: 23089737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombotic microangiopathy (TTP and HUS): advances in differentiation and diagnosis.
    Schneider M
    Clin Lab Sci; 2007; 20(4):216-20. PubMed ID: 18069446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant Hypertension Complicated By Renal Thrombotic Micro Angiopathy: Role Of Adam 13 Mutational Analyses.
    Aijazi I; Shama FA; Raman LG; Mukhtiar S
    J Ayub Med Coll Abbottabad; 2017; 29(3):502-505. PubMed ID: 29076694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recognition and treatment of syndromes linked to dysregulation of the alternative complement pathway.
    Laurence J
    Transfus Apher Sci; 2016 Apr; 54(2):179-80. PubMed ID: 27179927
    [No Abstract]   [Full Text] [Related]  

  • 18. The complex differential diagnosis between thrombotic thrombocytopenic purpura and the atypical hemolytic uremic syndrome: Laboratory weapons and their impact on treatment choice and monitoring.
    Mannucci PM; Cugno M
    Thromb Res; 2015 Nov; 136(5):851-4. PubMed ID: 26386489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How we manage thrombotic microangiopathies in pregnancy.
    Thomas MR; Robinson S; Scully MA
    Br J Haematol; 2016 Jun; 173(6):821-30. PubMed ID: 27019232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombotic microangiopathies (TTP, HUS, HELLP).
    Kappler S; Ronan-Bentle S; Graham A
    Emerg Med Clin North Am; 2014 Aug; 32(3):649-71. PubMed ID: 25060255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.